AllianceBernstein
BLFS icon

AllianceBernstein’s BioLife Solutions BLFS Stock Holding History

AllianceBernstein’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$966K Buy
50,650
+6,768
+15% +$158K ﹤0.01% 2405
2026
Q1 		$1.06M Sell
43,882
-130
-0.3% -$2.87K ﹤0.01% 2319
2025
Q4 		$1.06M Buy
44,012
+10,762
+32% +$282K ﹤0.01% 2313
2025
Q3 		$848K Sell
33,250
-77
-0.2% -$1.83K ﹤0.01% 2419
2025
Q2 		$718K Sell
33,327
-24
-0.1% -$541 ﹤0.01% 2459
2025
Q1 		$762K Sell
33,351
-4,000
-11% -$105K ﹤0.01% 2373
2024
Q4 		$970K Buy
37,351
+3,967
+12% +$98.7K ﹤0.01% 2354
2024
Q3 		$836K Sell
33,384
-510
-2% -$12K ﹤0.01% 2407
2024
Q2 		$726K Sell
33,894
-477
-1% -$9.26K ﹤0.01% 2465
2024
Q1 		$638K Buy
34,371
+134
+0.4% +$2.34K ﹤0.01% 2474
2023
Q4 		$556K Sell
34,237
-642
-2% -$8.19K ﹤0.01% 2561
2023
Q3 		$482K Buy
34,879
+5,050
+17% +$79.6K ﹤0.01% 2594
2023
Q2 		$659K Sell
29,829
-65
-0.2% -$1.37K ﹤0.01% 2494
2023
Q1 		$650K Sell
29,894
-4,984
-14% -$112K ﹤0.01% 2433
2022
Q4 		$635K Buy
34,878
+49
+0.1% +$1.01K ﹤0.01% 2504
2022
Q3 		$792K Buy
34,829
+2,189
+7% +$46.8K ﹤0.01% 2416
2022
Q2 		$451K Buy
32,640
+8,721
+36% +$128K ﹤0.01% 2718
2022
Q1 		$544K Sell
23,919
-11,150
-32% -$294K ﹤0.01% 2642
2021
Q4 		$1.31M Buy
35,069
+8,189
+30% +$351K ﹤0.01% 2360
2021
Q3 		$1.14M Buy
26,880
+4,080
+18% +$196K ﹤0.01% 2444
2021
Q2 		$1.01M Buy
22,800
+5,100
+29% +$180K ﹤0.01% 2527
2021
Q1 		$637K Sell
17,700
-2,600
-13% -$103K ﹤0.01% 2582
2020
Q4 		$810K Sell
20,300
-2,800
-12% -$95.5K ﹤0.01% 2389
2020
Q3 		$669K Hold
23,100
– – ﹤0.01% 2377
2020
Q2 		$378K Buy
23,100
+6,900
+43% +$95.1K ﹤0.01% 2780
2020
Q1 		$154K Buy
16,200
+5,800
+56% +$79.7K ﹤0.01% 2860
2019
Q4 		$168K Hold
10,400
– – ﹤0.01% 2956
2019
Q3 		$173K Buy
+10,400
New +$195K ﹤0.01% 2976

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AllianceBernstein's BLFS Position: Q2 2026 in Review

AllianceBernstein increased its BioLife Solutions (BLFS) stake by 15% in Q2 2026, buying an estimated $158K and bringing the position to 50,650 shares worth $966K. The position accounts for ﹤0.01% of the portfolio, ranked #2405.

AllianceBernstein first reported a position in BLFS in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.31M in Q4 2021. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • AllianceBernstein held 50,650 shares of BioLife Solutions worth $966K as of Q2 2026.
  • AllianceBernstein bought 6,768 BioLife Solutions shares in Q2 2026, an estimated $158K.
  • BioLife Solutions made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2405 holding.
  • AllianceBernstein first reported a position in BioLife Solutions in Q3 2019 and has held it in 28 quarters since.
  • AllianceBernstein's BioLife Solutions position peaked at $1.31M in Q4 2021.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.